Insider Transactions Reported by 15 Insiders of Lineage Cell Therapeutics, Inc.

Symbol
LCTX on NYSE
Location
Carlsbad, CA

Insiders trading volume in the past year

Lineage Cell Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
BROADWOOD PARTNERS, L.P. Director, 10%+ Owner $75,332,708 27 Jan 2025
Brian M. Culley President and CEO, Director $415,213 +$24,375 +6.2% 12 Mar 2026
Michael H. Mulroy Director $168,982 01 Jul 2025
Don M. Bailey Director $165,153 01 Jul 2024
George A. Samuel III General Counsel and Secretary $55,913 05 Mar 2026
Neal C. Bradsher Director, 10%+ Owner $52,500 01 Jul 2025
Anula Jayasuriya Director 01 Jul 2025
Angus C. Russell Director 01 Jul 2025
Dipti Amin Director 01 Jul 2025
Deborah J. Andrews Director 01 Jul 2025
Kevin Leon Cook Chief Financial Officer 10 Mar 2022
Alfred D. Kingsley Chairman, Director 01 Jul 2023
Gary S. Hogge SVP,Clinical & Medical Affairs 09 Mar 2023
Alexandra Hernandez Sr Director Finance/Controller 07 Jul 2022
Jill A. Howe Chief Financial Officer 05 Mar 2026

Recent Insider Transactions by Companies or Individuals for Lineage Cell Therapeutics, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Brian M. Culley LCTX Common Shares Purchase 6.24% $24,375 $1.62 15,000 255,516 12 Mar 2026 Direct
Brian M. Culley LCTX Employee Stock Option (Right to Buy) Award 3,250,000 3,250,000 05 Mar 2026 Direct
Jill A. Howe LCTX Employee Stock Option (Right to Buy) Award 1,050,000 1,050,000 05 Mar 2026 Direct
George A. Samuel III LCTX Employee Stock Option (Right to Buy) Award 900,000 900,000 05 Mar 2026 Direct
Brian M. Culley LCTX Common Shares Tax liability -5.08% -12,869 240,516 11 Feb 2026 Direct
Brian M. Culley LCTX Common Shares Options Exercise 14.1% 31,250 253,385 11 Feb 2026 Direct
Brian M. Culley LCTX Restricted Stock Units Options Exercise -100% -31,250 0 11 Feb 2026 Direct
George A. Samuel III LCTX Common Shares Tax liability -7.45% -2,502 31,063 11 Feb 2026 Direct
George A. Samuel III LCTX Common Shares Options Exercise 22.1% 6,075 33,565 11 Feb 2026 Direct
George A. Samuel III LCTX Restricted Stock Units Options Exercise -100% -6,075 0 11 Feb 2026 Direct
Brian M. Culley LCTX Common Shares Tax liability -0.15% -334 222,135 19 Dec 2025 Direct
Brian M. Culley LCTX Common Shares Award 4.18% 8,925 222,469 19 Dec 2025 Direct
George A. Samuel III LCTX Common Shares Tax liability -0.24% -65 27,490 19 Dec 2025 Direct
George A. Samuel III LCTX Common Shares Award 6.72% 1,735 27,555 19 Dec 2025 Direct
Neal C. Bradsher LCTX OPTION TO PURCHASE COMMON SHARES Award 75,000 75,000 01 Jul 2025 Direct
Dipti Amin LCTX Stock Option (Right to Buy) Award 75,000 75,000 01 Jul 2025 Direct
Anula Jayasuriya LCTX Stock Option (Right to Buy) Award 75,000 75,000 01 Jul 2025 Direct
Angus C. Russell LCTX Stock Option (Right to Buy) Award 75,000 75,000 01 Jul 2025 Direct
Michael H. Mulroy LCTX Stock Option (Right to Buy) Award 75,000 75,000 01 Jul 2025 Direct
Deborah J. Andrews LCTX Stock Option (Right to Buy) Award 75,000 75,000 01 Jul 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.